Authors


Bill Byrom, PhD

Latest:

Optimal COA Measurement Strategy in Modern Oncology Trials

Examining the two areas of weakness cited in FDA draft guidance.



Tom O’Leary

Latest:

Genomes, Big Data and the Journey to Precision Medicine

This month marks a landmark in the quest for personalized medicine and the growing role of big data in health sciences – from clinical development through tracking patient outcomes long after a therapy has reached the market.


Thaddeus Wolfram

Latest:

Wearables: Where is Clinical Development Headed Next?

The application of personal device technology in the health care space continues to evolve, fed by the development of health-related consumer products and services by segments of industry traditionally not focused on health


Heather Schultz

Latest:

Closing the Variance Gap: The Challenges with Clinical Trial Budget Management and Forecasting

As clinical trials continue to grow in complexity, tolerance for the growing variance between forecasted and actual clinical trial costs is shrinking.


Frederick Lewis

Latest:

Placebo Effect of Transdermal NSAIDS

The implications and challenges of the placebo effect on regulatory agency product approval.


Scott Kolodny, MD

Latest:

Safety Considerations for Follow-On Non-Biologic Complex Drugs

With patents for many NBCDs soon to expire, the need for regulatory guidance regarding follow-on versions of these products is crucial.


Dian Griesel, Ph.D.

Latest:

Clinical Trial Recruitment in the Digital Era: Some Smart Ideas

Challenging. Time-consuming. Expensive. Do words like these spring to mind when you contemplate the patient recruitment process for your clinical trials?


Sponsored Content

Latest:

Optimizing Clinical Trials Using Electronic Measurement and Analysis of Drug Adherence

Drug development has never before been so difficult, time consuming and expensive. Accuracy in clinical trials, therefore, is a priority



David Sahner, MD

Latest:

Machine Learning, Modeling, and Predictive Analytics: Key Principles for the Clinical Scientist

With the inherent limitations of traditional data sources, this overview explores the definitions and strategic fundamentals that inform machine learning and modeling techniques.


Vincent Schroyens

Latest:

Is There a Link Between Recruitment and Social Media?

A survey of Belgian clinical research professionals offers insights into the future of social media


Jessica Van Den Broeck

Latest:

Is There a Link Between Recruitment and Social Media?

A survey of Belgian clinical research professionals offers insights into the future of social media


Yves Geysels

Latest:

The African Medicines Agency: Impacts on the Continent’s Clinical Trials Regulation

Harmonization could turn the continent into an established site for clinical research and laboratories.




Arthur Wang

Latest:

Cloud Computing: Security in Clinical Trials

There is a lot of buzz about “the cloud.” Formally known as cloud computing, the cloud relies on sharing of Information Technology (IT) resources.


Wendy Tate

Latest:

A Critical Piece of the Research Puzzle: How Metrics Have Transformed Clinical Trials

Three key insights about clinical trial advancements made possible by the advent of metrics


Adrian Wildfire

Latest:

Human Challenge Studies in Early Phase Antiviral Development

The concept of the human challenge model (HCM) originated from early societal attempts to halt the spread of acute diseases within their own communities


Jonathan Rowe, PhD, MS, MA

Latest:

The Eradication of False Signals in Monitoring

How optimizing RBQM risk detection reduces the efforts caused by false signals.


Lori McKellar

Latest:

Targeting eTMF for Efficiency and Productivity Gains

In clinical trials, the ability to effectively plan, collect and maintain essential clinical trial documentation is challenging.


Paul Donnelly

Latest:

Expanding Data Management Services in China

EDC has become the data management platform of choice around the world, offering advantages such as increasing the quality and timely collection of data. Medrio, an EDC company that offers eClinical software solutions, has quoted that 70% of clinical trials are using EDC as a forms of collecting data in the United States. In China, we have seen adoption rates for EDC increase dramatically in recent years, fuelled by improved technology developments in mobile applications, and the increasing experience with EDC usage in clinical research.


Craig Morgan

Latest:

Millennials and their Impact on Clinical Research

The importance of examining this generation’s influence on the clinical trial value chain.


Katherine Ni

Latest:

The Employee Profile in China Pharma R&D

In this analysis, distinctions between who hires who in non-Chinese and China-based companies emerges.


Mathini Ilancheran

Latest:

Impact of Actigraphy in Clinical Research

With all the buzz around wearables, actigraphs-which monitor sleep and daytime activity levels-have been around for decades.


Juanjo Cardona

Latest:

The Employee Profile in China Pharma R&D

In this analysis, distinctions between who hires who in non-Chinese and China-based companies emerges.


Denise Calaprice-Whitty

Latest:

Bridging the Gap for Better Patient Engagement

A survey from the Avoca Group examines issues related to quality of clinical trials and trial participation from the patients' view.


Jeffry Liu

Latest:

Considerations for Clinical Trial Design in Public Health Emergencies

While the fundamental concerns behind the design of most modern clinical trials are effectively the same, clinical trials that take place during public health emergencies face additional layers of challenges.



Elizabeth Dalton

Latest:

Five Steps to Increase Site Satisfaction and Study Success

Over the past three decades, clinical imaging has become an integral part of the drug development process for biopharmaceutical companies.

© 2025 MJH Life Sciences

All rights reserved.